Faculty, Staff and Student Publications

Language

English

Publication Date

8-6-2024

Journal

Cell Metabolism

DOI

10.1016/j.cmet.2024.07.006

PMID

39111286

PMCID

PMC11315361

PubMedCentral® Posted Date

8-6-2025

PubMedCentral® Full Text Version

Author MSS

Abstract

A key challenge in aging research is to extend lifespan in tandem with slowing down functional decline so that the life with good health (healthspan) can be extended. Here, we show that monthly clearance of a small number of cells, which highly express p21Cip1 (p21high), starting from 20 months improves cardiac and metabolic function, and extends both median and maximum lifespan in mice. Importantly, by assessing health and physical function of these mice monthly until death, we show that clearance of p21high cells improves physical function at all remaining stages of life, suggesting healthspan extension. Mechanistically, p21high cells encompass several cell types, with a relatively conserved pro-inflammatory signature. Clearance of p21high cells reduces inflammation, and alleviates age-related transcriptomic signatures of various tissues. These findings demonstrate the feasibility of healthspan extension in mice, and indicate p21high cells as a therapeutic target for healthy aging.

Keywords

Animals, Cyclin-Dependent Kinase Inhibitor p21, Longevity, Mice, Mice, Inbred C57BL, Male, Aging, Female, cellular senescence, morbidity compression, inflammation, frailty, aging

Published Open-Access

yes

nihms-2010999-f0006.jpg (116 kB)
Graphical Abstract

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.